By expenditures
| Name | Title | Type |
|---|---|---|
| Theodora Rowan | Chief Financial Officer | Auditee |
| Charles Beady | Chief Executive Officer | Auditee |
| Charles Lindsya | SHAREHOLDER | Auditee |
| Charles Lindsay | Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 350653 | 2024 | 2025-03-31 | Matthews Curtrer & Lindsay P A | $29.41M |
| 299703 | 2023 | 2024-03-28 | Matthews Curtrer & Lindsay P A | $15.45M |
| 55294 | 2022 | 2023-02-09 | Matthews Curtrer & Lindsay P A | $25.76M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 350653 | 2024 | 2025-03-31 | 1117505 | 2024-001 | Significant Deficiency | - | E |
| 350653 | 2024 | 2025-03-31 | 1117504 | 2024-001 | Significant Deficiency | - | E |
| 350653 | 2024 | 2025-03-31 | 1117503 | 2024-001 | Significant Deficiency | - | E |
| 350653 | 2024 | 2025-03-31 | 541063 | 2024-001 | Significant Deficiency | - | E |
| 350653 | 2024 | 2025-03-31 | 541062 | 2024-001 | Significant Deficiency | - | E |
| 350653 | 2024 | 2025-03-31 | 541061 | 2024-001 | Significant Deficiency | - | E |
| 55294 | 2022 | 2023-02-09 | 634916 | 2022-001 | Significant Deficiency | - | E |
| 55294 | 2022 | 2023-02-09 | 634915 | 2022-001 | Significant Deficiency | - | E |
| 55294 | 2022 | 2023-02-09 | 58474 | 2022-001 | Significant Deficiency | - | E |
| 55294 | 2022 | 2023-02-09 | 58473 | 2022-001 | Significant Deficiency | - | E |